sl
0.25
0.5
0.75
1.25
1.5
1.75
2
Adjuvant trastuzumab in HER2-positive breast cancer
Published on 2013-06-183059 Views
Related categories
Presentation
Adjuvant Trastuzumab in HER2-Positive Breast Cancer00:00
Kaj je HER2+ rak dojke00:42
Opis klinične raziskave03:12
Rezultati06:27
Zaključki08:28